|Articles|November 19, 2015
Michael J. Mauro on Questions From Patients With CML
Author(s)Michael J. Mauro
Michael J. Mauro, provides an overview of some of the questions he hears from patients with chronic myeloid leukemia (CML).
Advertisement
Michael J. Mauro, leader, Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, provides an overview of some of the questions he hears from patients with chronic myeloid leukemia (CML).
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Hyrnuo in Some with Locally Advanced/Metastatic NSCLC
2
FDA Approves Imdelltra for Extensive-Stage Small Cell Lung Cancer
3
FDA Accepts NDA for Zidesamtinib in Previously Treated ROS1+ NSCLC
4
FDA Grants Fast Track Status to New Gastric Cancer Treatment
5
